ICCV Daily 2025 - Tuesday

new or to start working on something completely new. Sometimes you rediscover a lot of passion just by redirecting your interest towards something else for some time. What is the next thing that you're going to explore? There are a lot of interesting things that I have now that are somehow new. For example, I started recently to collaborate with the AI for science team that is also in Cambridge, working on cryo-EM data and a very powerful microscope to image proteins. They have some very interesting computer vision problems about how you select these particles. It is very much out of distribution with respect to what they do now. But that's actual work with them and it's very interesting. Did you already have the chance to see some of the things you worked on being translated into a realworld application? Yes. Yes. Yes. This is one of the most interesting parts for me. I really like that and it happened already a few times to me, in the company where I was working previously and here at Microsoft Research. Here we developed a pathology model that has been published on Nature and now it's under clinical trial with Cancer UK. Hopefully it will work. That was a very exciting project! They built a device that can extract some cells from the oesophagus. And based on that, they can make a prediction if you're at risk of cancer in your stomach. The problem is It's not scalable and too expensive. So what we did is to build the AI bit on top of it saying: once you have these images, you don't need to go through the traditional workflow of a pathologist reviewing several slides. There is this model and this will already make perfect predictions just using this understanding. We basically cut the cost utilizing AI. And if the clinical trial would have positive results, that means that it can be scaled at 21 DAILY ICCV Tuesday Valentina Salvatelli

RkJQdWJsaXNoZXIy NTc3NzU=